Anmol is a neuroscientist-turned-entrepreneur with a passion for bringing new drug therapies to market. After spending 8 years in the lab, he launched Nospharma to develop treatments for rare neurological disorders by repurposing shelved and on-market drugs to reduce the time and expense needed to get new therapies to patients. Anmol also serves as the Innovation & Strategy Associate at District 3, where he is a coach to early-stage biotech, biopharma, healthcare start-ups, helping them build and validate their business models. Prior to founding Nospharma, he worked in the healthcare system supporting the launch of rapid COVID testing platforms in Quebec.

Anmol holds and Master of Science in Neuroscience from McGill University and a Graduate Diploma in Business from Smith School of Business (Queen’s University), as well as a Bachelor of Arts and Science in Cognitive Science and Philosophy from McGill University.